APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmaceutical CRO Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmaceutical CRO Services Market Outlook and Growth Opportunities 2026

3 May 2026194 pages

Choose your research edition.

Industry ResearchPharmaceutical CRO Services Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmaceutical CRO Services Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Pharmaceutical CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmaceutical CRO Services Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pharmaceutical CRO Services Market Analysis and Forecast 2026-2032258 pages · $4,950 USD

Market perspective

The global Pharmaceutical CRO Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmaceutical CRO Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmaceutical CRO Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmaceutical CRO Services market include PPD (Thermo Fisher), Space Peptides, Aurigene Pharmaceutical Services, IQVIA, Labcorp Drug Development, Parexel, ICON plc, Syneos Health and Charles River Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmaceutical CRO Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmaceutical CRO Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmaceutical CRO Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmaceutical CRO Services market.

Pharmaceutical CRO Services Segment by Company

PPD (Thermo Fisher)

Space Peptides

Aurigene Pharmaceutical Services

IQVIA

Labcorp Drug Development

Parexel

ICON plc

Syneos Health

Charles River Laboratories

Medpace

SGS SA

KCR CRO

TFS HealthScience

Caidya

Worldwide Clinical Trials

CTI

Advanced Clinical

WuXi AppTec

Pharmaron Inc.

Hangzhou Tigermed Consulting

JOINN Laboratories

MEDICILON

Pharmaceutical CRO Services Segment by Type

Preclinical CRO

Clinical Trial CRO

Pharmaceutical CRO Services Segment by Application

Commercial

Scientific Research

Other

Pharmaceutical CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmaceutical CRO Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmaceutical CRO Services key companies, revenue, market share, and recent developments.

3. To split the Pharmaceutical CRO Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmaceutical CRO Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmaceutical CRO Services significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmaceutical CRO Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmaceutical CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmaceutical CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmaceutical CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmaceutical CRO Services industry.

Chapter 3: Detailed analysis of Pharmaceutical CRO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmaceutical CRO Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmaceutical CRO Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmaceutical CRO Services Industry Trends Table 2. Pharmaceutical CRO Services Industry Drivers Table 3. Pharmaceutical CRO Services Industry Opportunities and Challenges Table 4. Pharmaceutical CRO Services Industry Restraints Table 5. Global Pharmaceutical CRO Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmaceutical CRO Services Revenue Share by Company (2021-2026) Table 7. Global Pharmaceutical CRO Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmaceutical CRO Services Key Company Manufacturing Base & Headquarters Table 9. Global Pharmaceutical CRO Services Company, Product Type & Application Table 10. Global Pharmaceutical CRO Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmaceutical CRO Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Preclinical CRO Table 15. Significant Companies of Clinical Trial CRO Table 16. Global Pharmaceutical CRO Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pharmaceutical CRO Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pharmaceutical CRO Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pharmaceutical CRO Services Sales Value Share by Type (2021-2026) Table 20. Global Pharmaceutical CRO Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Commercial Table 22. Significant Companies of Scientific Research Table 23. Significant Companies of Other Table 24. Global Pharmaceutical CRO Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pharmaceutical CRO Services Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pharmaceutical CRO Services Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pharmaceutical CRO Services Sales Value Share by Application (2021-2026) Table 28. Global Pharmaceutical CRO Services Sales Value Share by Application (2027-2032) Table 29. Global Pharmaceutical CRO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pharmaceutical CRO Services Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pharmaceutical CRO Services Sales Value Share by Region (2021-2026) Table 32. Global Pharmaceutical CRO Services Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pharmaceutical CRO Services Sales Value Share by Region (2027-2032) Table 34. Global Pharmaceutical CRO Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pharmaceutical CRO Services Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pharmaceutical CRO Services Sales Value Market Share by Country (2021-2026) Table 37. Global Pharmaceutical CRO Services Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pharmaceutical CRO Services Sales Value Market Share by Country (2027-2032) Table 39. PPD (Thermo Fisher) Company Information Table 40. PPD (Thermo Fisher) Business Overview Table 41. PPD (Thermo Fisher) Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. PPD (Thermo Fisher) Pharmaceutical CRO Services Product Portfolio Table 43. PPD (Thermo Fisher) Recent Development Table 44. Space Peptides Company Information Table 45. Space Peptides Business Overview Table 46. Space Peptides Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Space Peptides Pharmaceutical CRO Services Product Portfolio Table 48. Space Peptides Recent Development Table 49. Aurigene Pharmaceutical Services Company Information Table 50. Aurigene Pharmaceutical Services Business Overview Table 51. Aurigene Pharmaceutical Services Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Aurigene Pharmaceutical Services Pharmaceutical CRO Services Product Portfolio Table 53. Aurigene Pharmaceutical Services Recent Development Table 54. IQVIA Company Information Table 55. IQVIA Business Overview Table 56. IQVIA Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. IQVIA Pharmaceutical CRO Services Product Portfolio Table 58. IQVIA Recent Development Table 59. Labcorp Drug Development Company Information Table 60. Labcorp Drug Development Business Overview Table 61. Labcorp Drug Development Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Labcorp Drug Development Pharmaceutical CRO Services Product Portfolio Table 63. Labcorp Drug Development Recent Development Table 64. Parexel Company Information Table 65. Parexel Business Overview Table 66. Parexel Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Parexel Pharmaceutical CRO Services Product Portfolio Table 68. Parexel Recent Development Table 69. ICON plc Company Information Table 70. ICON plc Business Overview Table 71. ICON plc Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. ICON plc Pharmaceutical CRO Services Product Portfolio Table 73. ICON plc Recent Development Table 74. Syneos Health Company Information Table 75. Syneos Health Business Overview Table 76. Syneos Health Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Syneos Health Pharmaceutical CRO Services Product Portfolio Table 78. Syneos Health Recent Development Table 79. Charles River Laboratories Company Information Table 80. Charles River Laboratories Business Overview Table 81. Charles River Laboratories Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Charles River Laboratories Pharmaceutical CRO Services Product Portfolio Table 83. Charles River Laboratories Recent Development Table 84. Medpace Company Information Table 85. Medpace Business Overview Table 86. Medpace Pharmaceutical CRO Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Medpace Pharmaceutical CRO Services Product Portfolio Table 88. Medpace Recent Development Table 89. SGS SA Company Information Table 90. SGS SA Business Overview Table 91. SGS SA Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. SGS SA Pharmaceutical CRO Services Product Portfolio Table 93. SGS SA Recent Development Table 94. KCR CRO Company Information Table 95. KCR CRO Business Overview Table 96. KCR CRO Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. KCR CRO Pharmaceutical CRO Services Product Portfolio Table 98. KCR CRO Recent Development Table 99. TFS HealthScience Company Information Table 100. TFS HealthScience Business Overview Table 101. TFS HealthScience Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. TFS HealthScience Pharmaceutical CRO Services Product Portfolio Table 103. TFS HealthScience Recent Development Table 104. Caidya Company Information Table 105. Caidya Business Overview Table 106. Caidya Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Caidya Pharmaceutical CRO Services Product Portfolio Table 108. Caidya Recent Development Table 109. Worldwide Clinical Trials Company Information Table 110. Worldwide Clinical Trials Business Overview Table 111. Worldwide Clinical Trials Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Worldwide Clinical Trials Pharmaceutical CRO Services Product Portfolio Table 113. Worldwide Clinical Trials Recent Development Table 114. CTI Company Information Table 115. CTI Business Overview Table 116. CTI Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. CTI Pharmaceutical CRO Services Product Portfolio Table 118. CTI Recent Development Table 119. Advanced Clinical Company Information Table 120. Advanced Clinical Business Overview Table 121. Advanced Clinical Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Advanced Clinical Pharmaceutical CRO Services Product Portfolio Table 123. Advanced Clinical Recent Development Table 124. WuXi AppTec Company Information Table 125. WuXi AppTec Business Overview Table 126. WuXi AppTec Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. WuXi AppTec Pharmaceutical CRO Services Product Portfolio Table 128. WuXi AppTec Recent Development Table 129. Pharmaron Inc. Company Information Table 130. Pharmaron Inc. Business Overview Table 131. Pharmaron Inc. Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. Pharmaron Inc. Pharmaceutical CRO Services Product Portfolio Table 133. Pharmaron Inc. Recent Development Table 134. Hangzhou Tigermed Consulting Company Information Table 135. Hangzhou Tigermed Consulting Business Overview Table 136. Hangzhou Tigermed Consulting Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Hangzhou Tigermed Consulting Pharmaceutical CRO Services Product Portfolio Table 138. Hangzhou Tigermed Consulting Recent Development Table 139. JOINN Laboratories Company Information Table 140. JOINN Laboratories Business Overview Table 141. JOINN Laboratories Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. JOINN Laboratories Pharmaceutical CRO Services Product Portfolio Table 143. JOINN Laboratories Recent Development Table 144. MEDICILON Company Information Table 145. MEDICILON Business Overview Table 146. MEDICILON Pharmaceutical CRO Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. MEDICILON Pharmaceutical CRO Services Product Portfolio Table 148. MEDICILON Recent Development Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Pharmaceutical CRO Services Product Image Figure 2. Global Pharmaceutical CRO Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmaceutical CRO Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmaceutical CRO Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Preclinical CRO Image Figure 8. Clinical Trial CRO Image Figure 9. Global Pharmaceutical CRO Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pharmaceutical CRO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pharmaceutical CRO Services Sales Value Share by Type (2021-2032) Figure 12. Commercial Image Figure 13. Scientific Research Image Figure 14. Other Image Figure 15. Global Pharmaceutical CRO Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pharmaceutical CRO Services Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pharmaceutical CRO Services Sales Value Share by Application (2021-2032) Figure 18. Global Pharmaceutical CRO Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pharmaceutical CRO Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pharmaceutical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pharmaceutical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pharmaceutical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pharmaceutical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pharmaceutical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pharmaceutical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pharmaceutical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pharmaceutical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pharmaceutical CRO Services Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pharmaceutical CRO Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical Trial CRO
Applications
  • Commercial
  • Scientific Research
  • Other
Companies covered
  • PPD (Thermo Fisher)
  • Space Peptides
  • Aurigene Pharmaceutical Services
  • IQVIA
  • Labcorp Drug Development
  • Parexel
  • ICON plc
  • Syneos Health
  • Charles River Laboratories
  • Medpace
  • SGS SA
  • KCR CRO
  • TFS HealthScience
  • Caidya
  • Worldwide Clinical Trials
  • CTI
  • Advanced Clinical
  • WuXi AppTec
  • Pharmaron Inc.
  • Hangzhou Tigermed Consulting
  • JOINN Laboratories
  • MEDICILON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmaceutical CRO Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmaceutical CRO Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmaceutical CRO Services Market Dynamics
  1. 2.1 Pharmaceutical CRO Services Industry Trends
  2. 2.2 Pharmaceutical CRO Services Industry Drivers
  3. 2.3 Pharmaceutical CRO Services Industry Opportunities and Challenges
  4. 2.4 Pharmaceutical CRO Services Industry Restraints
3 Pharmaceutical CRO Services Market by Company
  1. 3.1 Global Pharmaceutical CRO Services Company Revenue Ranking in 2025
  2. 3.2 Global Pharmaceutical CRO Services Revenue by Company (2021-2026)
  3. 3.3 Global Pharmaceutical CRO Services Company Ranking (2024-2026)
  4. 3.4 Global Pharmaceutical CRO Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmaceutical CRO Services Company Product Type and Application
  6. 3.6 Global Pharmaceutical CRO Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmaceutical CRO Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmaceutical CRO Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmaceutical CRO Services Market by Type
  1. 4.1 Pharmaceutical CRO Services Type Introduction
  2. 4.1.1 Preclinical CRO
  3. 4.1.2 Clinical Trial CRO
  4. 4.2 Global Pharmaceutical CRO Services Sales Value by Type
  5. 4.2.1 Global Pharmaceutical CRO Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pharmaceutical CRO Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pharmaceutical CRO Services Sales Value Share by Type (2021-2032)
5 Pharmaceutical CRO Services Market by Application
  1. 5.1 Pharmaceutical CRO Services Application Introduction
  2. 5.1.1 Commercial
  3. 5.1.2 Scientific Research
  4. 5.1.3 Other
  5. 5.2 Global Pharmaceutical CRO Services Sales Value by Application
  6. 5.2.1 Global Pharmaceutical CRO Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pharmaceutical CRO Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pharmaceutical CRO Services Sales Value Share by Application (2021-2032)
6 Pharmaceutical CRO Services Regional Value Analysis
  1. 6.1 Global Pharmaceutical CRO Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmaceutical CRO Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmaceutical CRO Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmaceutical CRO Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmaceutical CRO Services Sales Value (2021-2032)
  7. 6.3.2 North America Pharmaceutical CRO Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmaceutical CRO Services Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmaceutical CRO Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmaceutical CRO Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmaceutical CRO Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmaceutical CRO Services Sales Value (2021-2032)
  16. 6.6.2 South America Pharmaceutical CRO Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmaceutical CRO Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmaceutical CRO Services Sales Value Share by Country, 2025 VS 2032
7 Pharmaceutical CRO Services Country-level Value Analysis
  1. 7.1 Global Pharmaceutical CRO Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmaceutical CRO Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmaceutical CRO Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmaceutical CRO Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmaceutical CRO Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmaceutical CRO Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmaceutical CRO Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 PPD (Thermo Fisher)
  2. 8.1.1 PPD (Thermo Fisher) Company Information
  3. 8.1.2 PPD (Thermo Fisher) Business Overview
  4. 8.1.3 PPD (Thermo Fisher) Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 PPD (Thermo Fisher) Pharmaceutical CRO Services Product Portfolio
  6. 8.1.5 PPD (Thermo Fisher) Recent Developments
  7. 8.2 Space Peptides
  8. 8.2.1 Space Peptides Company Information
  9. 8.2.2 Space Peptides Business Overview
  10. 8.2.3 Space Peptides Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Space Peptides Pharmaceutical CRO Services Product Portfolio
  12. 8.2.5 Space Peptides Recent Developments
  13. 8.3 Aurigene Pharmaceutical Services
  14. 8.3.1 Aurigene Pharmaceutical Services Company Information
  15. 8.3.2 Aurigene Pharmaceutical Services Business Overview
  16. 8.3.3 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aurigene Pharmaceutical Services Pharmaceutical CRO Services Product Portfolio
  18. 8.3.5 Aurigene Pharmaceutical Services Recent Developments
  19. 8.4 IQVIA
  20. 8.4.1 IQVIA Company Information
  21. 8.4.2 IQVIA Business Overview
  22. 8.4.3 IQVIA Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IQVIA Pharmaceutical CRO Services Product Portfolio
  24. 8.4.5 IQVIA Recent Developments
  25. 8.5 Labcorp Drug Development
  26. 8.5.1 Labcorp Drug Development Company Information
  27. 8.5.2 Labcorp Drug Development Business Overview
  28. 8.5.3 Labcorp Drug Development Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Labcorp Drug Development Pharmaceutical CRO Services Product Portfolio
  30. 8.5.5 Labcorp Drug Development Recent Developments
  31. 8.6 Parexel
  32. 8.6.1 Parexel Company Information
  33. 8.6.2 Parexel Business Overview
  34. 8.6.3 Parexel Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Parexel Pharmaceutical CRO Services Product Portfolio
  36. 8.6.5 Parexel Recent Developments
  37. 8.7 ICON plc
  38. 8.7.1 ICON plc Company Information
  39. 8.7.2 ICON plc Business Overview
  40. 8.7.3 ICON plc Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ICON plc Pharmaceutical CRO Services Product Portfolio
  42. 8.7.5 ICON plc Recent Developments
  43. 8.8 Syneos Health
  44. 8.8.1 Syneos Health Company Information
  45. 8.8.2 Syneos Health Business Overview
  46. 8.8.3 Syneos Health Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Syneos Health Pharmaceutical CRO Services Product Portfolio
  48. 8.8.5 Syneos Health Recent Developments
  49. 8.9 Charles River Laboratories
  50. 8.9.1 Charles River Laboratories Company Information
  51. 8.9.2 Charles River Laboratories Business Overview
  52. 8.9.3 Charles River Laboratories Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Charles River Laboratories Pharmaceutical CRO Services Product Portfolio
  54. 8.9.5 Charles River Laboratories Recent Developments
  55. 8.10 Medpace
  56. 8.10.1 Medpace Company Information
  57. 8.10.2 Medpace Business Overview
  58. 8.10.3 Medpace Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Medpace Pharmaceutical CRO Services Product Portfolio
  60. 8.10.5 Medpace Recent Developments
  61. 8.11 SGS SA
  62. 8.11.1 SGS SA Company Information
  63. 8.11.2 SGS SA Business Overview
  64. 8.11.3 SGS SA Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 SGS SA Pharmaceutical CRO Services Product Portfolio
  66. 8.11.5 SGS SA Recent Developments
  67. 8.12 KCR CRO
  68. 8.12.1 KCR CRO Company Information
  69. 8.12.2 KCR CRO Business Overview
  70. 8.12.3 KCR CRO Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 KCR CRO Pharmaceutical CRO Services Product Portfolio
  72. 8.12.5 KCR CRO Recent Developments
  73. 8.13 TFS HealthScience
  74. 8.13.1 TFS HealthScience Company Information
  75. 8.13.2 TFS HealthScience Business Overview
  76. 8.13.3 TFS HealthScience Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 TFS HealthScience Pharmaceutical CRO Services Product Portfolio
  78. 8.13.5 TFS HealthScience Recent Developments
  79. 8.14 Caidya
  80. 8.14.1 Caidya Company Information
  81. 8.14.2 Caidya Business Overview
  82. 8.14.3 Caidya Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Caidya Pharmaceutical CRO Services Product Portfolio
  84. 8.14.5 Caidya Recent Developments
  85. 8.15 Worldwide Clinical Trials
  86. 8.15.1 Worldwide Clinical Trials Company Information
  87. 8.15.2 Worldwide Clinical Trials Business Overview
  88. 8.15.3 Worldwide Clinical Trials Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Worldwide Clinical Trials Pharmaceutical CRO Services Product Portfolio
  90. 8.15.5 Worldwide Clinical Trials Recent Developments
  91. 8.16 CTI
  92. 8.16.1 CTI Company Information
  93. 8.16.2 CTI Business Overview
  94. 8.16.3 CTI Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CTI Pharmaceutical CRO Services Product Portfolio
  96. 8.16.5 CTI Recent Developments
  97. 8.17 Advanced Clinical
  98. 8.17.1 Advanced Clinical Company Information
  99. 8.17.2 Advanced Clinical Business Overview
  100. 8.17.3 Advanced Clinical Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Advanced Clinical Pharmaceutical CRO Services Product Portfolio
  102. 8.17.5 Advanced Clinical Recent Developments
  103. 8.18 WuXi AppTec
  104. 8.18.1 WuXi AppTec Company Information
  105. 8.18.2 WuXi AppTec Business Overview
  106. 8.18.3 WuXi AppTec Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 WuXi AppTec Pharmaceutical CRO Services Product Portfolio
  108. 8.18.5 WuXi AppTec Recent Developments
  109. 8.19 Pharmaron Inc.
  110. 8.19.1 Pharmaron Inc. Company Information
  111. 8.19.2 Pharmaron Inc. Business Overview
  112. 8.19.3 Pharmaron Inc. Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Pharmaron Inc. Pharmaceutical CRO Services Product Portfolio
  114. 8.19.5 Pharmaron Inc. Recent Developments
  115. 8.20 Hangzhou Tigermed Consulting
  116. 8.20.1 Hangzhou Tigermed Consulting Company Information
  117. 8.20.2 Hangzhou Tigermed Consulting Business Overview
  118. 8.20.3 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Hangzhou Tigermed Consulting Pharmaceutical CRO Services Product Portfolio
  120. 8.20.5 Hangzhou Tigermed Consulting Recent Developments
  121. 8.21 JOINN Laboratories
  122. 8.21.1 JOINN Laboratories Company Information
  123. 8.21.2 JOINN Laboratories Business Overview
  124. 8.21.3 JOINN Laboratories Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 JOINN Laboratories Pharmaceutical CRO Services Product Portfolio
  126. 8.21.5 JOINN Laboratories Recent Developments
  127. 8.22 MEDICILON
  128. 8.22.1 MEDICILON Company Information
  129. 8.22.2 MEDICILON Business Overview
  130. 8.22.3 MEDICILON Pharmaceutical CRO Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 MEDICILON Pharmaceutical CRO Services Product Portfolio
  132. 8.22.5 MEDICILON Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst